◼ Archived
Business
🔮 fades
Alzheimer's: Real-world study confirms Leqembi therapy benefits
The FDA has approved an at-home subcutaneous starter dose for the Alzheimer's drug Leqembi, supported by real-world evidence of therapy benefits.